Close X
Attorney Spotlight

How did Mike DeAgro's experience co-founding a nonprofit advocacy organization lead to a career in the legal field? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

Envision to Sell to KKR for $9.9 Billion

We represented Envision Healthcare Corporation (NYSE: EVHC) in its definitive agreement to sell to KKR in an all-cash transaction for $9.9 billion, including debt. KKR will pay $46 per Envision share in cash to buy the company, marking a 32 percent premium to the company's volume-weighted average share price from November 1, when Envision announced it was considering its options. The transaction is expected to close the fourth quarter of 2018. Read more


Envision Healthcare

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Six Things to Know Before Buying a Physician Practice spotlight

Dermatology, ophthalmology, radiology, urology…the list goes on. Yet, in any physician practice management transaction, there are six key considerations that apply and, if not carefully managed, can derail a transaction. Download the 6 Things to Know Before Buying a Physician Practice to keep your physician practice management transactions on track.

Click here to download the guide.

Dale Grimes Authors Article on Antitrust Focus in Healthcare Consolidations

Becker's Hospital Review

Publications

June 20, 2016

Bass, Berry & Sims attorney Dale Grimes authored an article for Becker's Hospital Review outlining the antitrust concerns that can accompany healthcare consolidations. As Dale points out in the article, "[w]hether by merger or acquisition, joint venture, clinical integration, or some other form of alignment, consolidating or affiliating with other provider organizations carries the risk of an antitrust investigation and challenge by federal or state enforcers, and often both." According to research cited in the article, nearly "half of the FTC's enforcement actions were in the healthcare sector from 2011 to 2015, with 24% in 'Health Care–General,' and 26% in 'Health Care–Pharmaceuticals & Medical Devices.'"

Dale also discusses several recent antitrust cases and outlines some lessons learned from these , such as:

  1. The FTC as well as state enforcers are indeed watching. 
  2. The number of physicians joining together in a group merger is not a determining factor. 
  3. Planning a merger for the sole purpose of increasing bargaining power is unwise and dangerous.
  4. Bad documents can sink a merger.

The full article, "Under the Microscope, Antitrust Enforcers Focus on Healthcare Consolidations," was published by Becker's Hospital Review on June 20, 2016, and is available online.


In Case You Missed It:

Related Professionals

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.